Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
English (EN)
NITAG documentation
2021
Americas
Clear all
Type of publications
NITAG documentation
(50)
Topics
Background paper
(26)
Recommendation
(24)
Available to download in languages
English (EN)
(50)
Spanish (ES)
(11)
French (FR)
(4)
Regions
Americas
(50)
Africa
(13)
Europe
(36)
South-East Asia
(2)
Western Pacific
(11)
Countries
Bolivia
(1)
Canada
(15)
United States of America
(34)
Diseases
COVID-19
(50)
Ebola
(1)
Vaccine topics
Target population
Adults
(1)
Children
(2)
Pregnant women
(2)
Publication date
2021
(50)
2024
(1)
2023
(6)
2022
(24)
2020
(51)
50 results found
2021
∙
NACI
NACI rapid response: Recommended use of AstraZeneca COVID-19 vaccine in younger adults
2021
∙
ACIP
Overview of Janssen’s Single-Dose COVID-19 Vaccine, Ad26.COV2.S
2021
∙
NACI
Rapid response: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 vaccines
2021
∙
NACI
Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5-11 years of age
2021
∙
NACI, Public Health Agency of Canada
Recommendations on the use of COVID-19 Vaccines
2021
∙
NACI
Recommendations on the use of COVID-19 Vaccines
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine
2021
∙
ACIP
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update of ACIP - 9 July 2021
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register